Advertisement
Canada markets closed
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7306
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    79.67
    +0.41 (+0.52%)
     
  • Bitcoin CAD

    86,058.80
    +1,814.20 (+2.15%)
     
  • CMC Crypto 200

    1,351.01
    +50.91 (+3.92%)
     
  • GOLD FUTURES

    2,356.70
    +16.40 (+0.70%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    18,219.00
    +4.50 (+0.02%)
     
  • VOLATILITY

    12.69
    -0.31 (-2.38%)
     
  • FTSE

    8,381.35
    +27.30 (+0.33%)
     
  • NIKKEI 225

    38,335.79
    +261.81 (+0.69%)
     
  • CAD/EUR

    0.6777
    -0.0001 (-0.01%)
     

Zynex Sets First Quarter 2024 Earnings Call

ENGLEWOOD, Colo., April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024.  Financial results will be issued in a press release prior to the call.

Zynex
Zynex

Zynex management will host the conference call, followed by a question and answer session.

Date: Tuesday, April 30, 2024
Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)
U.S. & Canada dial-in number: 800-836-8184
International number: 646-357-8785
Webcast: 1Q 2024 Webcast Link

ADVERTISEMENT

The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-sets-first-quarter-2024-earnings-call-302120512.html

SOURCE Zynex